(250mg)Gefitinib

Gefitinib (250mg)
GEFISTERIS 250  is a medication used in the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene. GEFISTERIS 250 belongs to a class of drugs called tyrosine kinase inhibitors (TKIs).
The standard recommended dosage of GEFISTERIS 250 for NSCLC is 250 mg, taken orally once daily. It is important to follow the specific dosing instructions provided by your healthcare provider, as they may vary based on your individual condition and other factors.
GEFISTERIS 250 works by inhibiting the activity of the EGFR protein, which is involved in the growth and spread of cancer cells. By blocking this protein, GEFISTERIS 250 helps to slow down or stop the growth of cancer cells, thereby reducing the size of tumors.
STERIS PHARMA Generic medicines are typically much cheaper than brand-name drugs. Generic medicines have the same active ingredients, strength, dosage form, and route of administration as their brand-name counterparts.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/gefisteris-250-133658